![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Aneuploidy - 102 Studies Found
Terminated |
: Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies :
|
Terminated |
: Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer :
|
Recruiting |
: Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers :
|
Completed |
: Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5 :
: 2008-09-26 : Drug: lenalidomide Initial dose is oral lenalidomide 10 mg daily continuously. The dose should be increa |
Completed |
: Blastocyst Euploidy Assessment and Conditioned embryO traNsfer : Infertility : 2015-01-28 : Other: PGS Embryos screened by the validated NGS technology CNV-Seq |
Completed |
: Next Generation Sequencing Screening for Embryonic Ploidy Status : Infertility : 2014-01-07 :
|
Completed |
: Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA : Trisomy 21 : 2013-04-14 : Procedure: cell-free fetal DNA cell-free fetal DNA for DBS and maternal serum screening high risk pregna |
Completed |
: Non-invasive Chromosomal Examination of Trisomy Study : Trisomy 21 : 2012-01-13 |
Recruiting |
: Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype : Acute Myeloid Leukemia : 2012-02-13 : Drug: sorafenib, vorinostat and bortezomib Escalating dose cohorts of sorafenib, vorinostat and bortezom |